Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 288 entries
View as:

A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia

Phase: N/A Priority: Normal
NCT ID: NCT06916793 Org: User:
Start: 04/30/25 End: 09/17/27 Due: 09/17/28

Drug Interaction Between CKD-501 and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01005160 Org: User:
Start: 10/31/09 End: 02/28/10 Due: 02/28/11

Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT05193565 Org: User:
Start: 11/19/21 End: 06/30/24 Due: 06/30/25

A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients

Phase: N/A Priority: Normal
NCT ID: NCT05050604 Org: User:
Start: 09/30/21 End: 11/30/24 Due: 11/30/25

Drug-drug Interaction Study (CKD-501, Ketoconazole)

Phase: N/A Priority: Normal
NCT ID: NCT01330563 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg

Phase: N/A Priority: Normal
NCT ID: NCT05698043 Org: User:
Start: 07/17/23 End: 09/26/23 Due: 09/26/24

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02685774 Org: User:
Start: 02/29/16 End: 04/30/16 Due: 04/30/17

Compare the Pharmacokinetics and Safety of CKD-391

Phase: N/A Priority: Normal
NCT ID: NCT04354987 Org: User:
Start: 10/30/19 End: 01/09/20 Due: 01/09/21

A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012

Phase: N/A Priority: Normal
NCT ID: NCT04035538 Org: User:
Start: 08/31/19 End: 12/31/19 Due: 12/31/20

Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04488900 Org: User:
Start: 07/06/20 End: 07/02/23 Due: 07/02/24

A Clinical Trial to Evaluate the Food Effect of CKD-378

Phase: N/A Priority: Normal
NCT ID: NCT06386328 Org: User:
Start: 05/03/24 End: 06/13/24 Due: 06/13/25

Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01560325 Org: User:
Start: 06/30/12 End: 10/31/14 Due: 10/31/15

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04867200 Org: User:
Start: 04/27/21 End: 06/01/21 Due: 06/01/22

CKD-828(80/2.5mg) Pharmacokinetic Study_2nd

Phase: N/A Priority: Normal
NCT ID: NCT01352689 Org: User:
Start: 04/30/11 End: 05/31/11 Due: 05/31/12

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03920579 Org: User:
Start: 04/01/19 End: 05/31/19 Due: 05/31/20

Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)

Phase: N/A Priority: Normal
NCT ID: NCT04069065 Org: User:
Start: 07/31/19 End: 04/08/21 Due: 04/08/22

Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1

Phase: N/A Priority: Normal
NCT ID: NCT04156685 Org: User:
Start: 08/06/19 End: 10/02/19 Due: 10/02/20

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386

Phase: N/A Priority: Normal
NCT ID: NCT04673864 Org: User:
Start: 01/17/21 End: 03/30/21 Due: 03/30/22

CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)

Phase: N/A Priority: Normal
NCT ID: NCT03569579 Org: User:
Start: 04/16/18 End: 06/04/18 Due: 06/04/19

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

Phase: N/A Priority: Normal
NCT ID: NCT05749861 Org: User:
Start: 04/22/23 End: 07/18/23 Due: 07/18/24

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)

Phase: N/A Priority: Normal
NCT ID: NCT04083872 Org: User:
Start: 09/06/19 End: 11/01/19 Due: 11/01/20

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04272502 Org: User:
Start: 06/04/19 End: 08/26/19 Due: 08/26/20

CKD-828 (80/5mg) Pharmacokinetic Study

Phase: N/A Priority: Normal
NCT ID: NCT02358824 Org: User:
Start: 02/28/15 End: 06/30/15 Due: 06/30/16

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Phase: N/A Priority: Normal
NCT ID: NCT03210649 Org: User:
Start: 03/07/17 End: 04/24/17 Due: 04/24/18

Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01016626 Org: User:
Start: 07/31/09 End: 10/31/09 Due: 10/31/10